Skip to content
Advertisement

FILE - This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan has finalized a $465 million federal agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade, charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government. (AP Photo/Mark Zaleski, File)

FILE - This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan has finalized a $465 million federal agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade, charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government. (AP Photo/Mark Zaleski, File)

Featured Photo Galleries